AAAAAA
Results:
1-19
|
Results: 19
Authors:
BRANCHI A
ROVELLINI A
TORRI A
SOMMARIVA D
Citation: A. Branchi et al., ACCURACY OF CALCULATED SERUM LOW-DENSITY-LIPOPROTEIN CHOLESTEROL FOR THE ASSESSMENT OF CORONARY HEART-DISEASE RISK IN NIDDM PATIENTS, Diabetes care, 21(9), 1998, pp. 1397-1402
Authors:
BRANCHI A
ROVELLINI A
FIORENZA AM
SOMMARIVA D
Citation: A. Branchi et al., EFFECTS OF MICRONIZED FENOFIBRATE ON APO-A DEFINED HDL SUBFRACTIONS IN PATIENTS WITH COMBINED HYPERLIPIDEMIA, Atherosclerosis (Amsterdam), 138, 1998, pp. 28-28
Authors:
BRANCHI A
ROVELLINI A
TORRI A
CASTAGNOLA G
ARCANGELI L
GASPERINI S
BONINI M
RE L
MARCHETTI L
WINKLER S
SOMMARIVA D
Citation: A. Branchi et al., EFFECTS OF ORAL HORMONE REPLACEMENT THERAPY ON APO-A DEFINED HDL SUBFRACTIONS IN POSTMENOPAUSAL WOMEN, Atherosclerosis (Amsterdam), 138, 1998, pp. 29-29
Authors:
SOMMARIVA D
BRANCHI A
FIORENZA AM
ROVELLINI A
Citation: D. Sommariva et al., LOWERING EFFECT OF SIMVASTATIN ON SERUM TRIGLYCERIDES IN PATIENTS WITH COMBINED HYPERLIPIDEMIA, Atherosclerosis (Amsterdam), 138, 1998, pp. 54-54
Authors:
BRANCHI A
ROVELLINI A
TOMELLA C
SCIARIADA L
TORRI A
MOLGORA M
SOMMARIVA D
Citation: A. Branchi et al., ASSOCIATION OF ALCOHOL-CONSUMPTION WITH HDL SUBPOPULATIONS DEFINED BYAPOLIPOPROTEIN-A-I AND APOLIPOPROTEIN A-II CONTENT, European journal of clinical nutrition, 51(6), 1997, pp. 362-365
Authors:
BRANCHI A
ROVELLINI A
SOMMARIVA D
Citation: A. Branchi et al., FLUVASTATIN INCREASES SERUM CONCENTRATION OF HDL PARTICLES CONTAININGAPOLIPOPROTEIN-A-I IN HYPERCHOLESTEROLEMIC PATIENTS, Atherosclerosis, 134(1-2), 1997, pp. 54-54
Authors:
BRANCHI A
FIORENZA AM
ROVELLINI A
SOMMARIVA D
Citation: A. Branchi et al., A COMPARATIVE-STUDY ON THE EFFECTS OF FLUVASTATIN AND SIMVASTATIN ON SERUM-LIPOPROTEINS IN HYPERCHOLESTEROLEMIC PATIENTS, Atherosclerosis, 134(1-2), 1997, pp. 121-121
Authors:
BRANCHI A
ROVELLINI A
ARCANGELI L
RE L
BONINI M
TORRI A
MARCHETTI L
SOMMARIVA D
Citation: A. Branchi et al., IMMUNOQUANTIFICATION OF LIPOPROTEIN(A) - A COMPARATIVE-EVALUATION OF 4 METHODS, Atherosclerosis, 134(1-2), 1997, pp. 138-138
Authors:
ROVELLINI A
BRANCHI A
FIORENZA AM
SOMMARIVA D
Citation: A. Rovellini et al., ONE-YEAR EXPERIENCE WITH SIMVASTATIN IN PATIENTS OVER 65 WITH PRIMARYHYPERCHOLESTEROLEMIA, Atherosclerosis, 134(1-2), 1997, pp. 174-174
Authors:
ROVELLINI A
BRANCHI A
ARCANGELI L
RE L
MARCHETTI L
SOMMARIVA D
Citation: A. Rovellini et al., LACK OF AN EFFECT OF PHYSICAL EXERCISE ON THE SERUM CONCENTRATION OF HDL SUBFRACTIONS CONTAINING APO A-I WITH AND WITHOUT APOA-II, Atherosclerosis, 134(1-2), 1997, pp. 372-372
Authors:
TORRI A
BRANCHI A
ROVELLINI A
GASPERINI S
SOMMARIVA D
Citation: A. Torri et al., EFFECT OF FLUVASTATIN ON SERUM-LIPOPROTEINS AND GLYCEMIC CONTROL IN HYPERLIPIDEMIC PATIENTS WITH TYPE-II DIABETES, Atherosclerosis, 134(1-2), 1997, pp. 384-384
Authors:
BRANCHI A
ROVELLINI A
FIORENZA AM
MARAFFI F
GANDINI R
SOMMARIVA D
Citation: A. Branchi et al., THE EFFECT OF SIMVASTATIN ON HDL CHOLESTEROL IN HYPERLIPIDEMIC PATIENTS - EVIDENCE OF A RELATIONSHIP WITH THE CHANGES IN SERUM TRIGLYCERIDELEVEL, International journal of clinical pharmacology and therapeutics, 34(9), 1996, pp. 384-389
Authors:
FIORENZA AM
BRANCHI A
CARDENA A
MOLGORA M
ROVELLINI A
SOMMARIVA D
Citation: Am. Fiorenza et al., SERUM-CHOLESTEROL LEVELS IN PATIENTS WITH CANCER - RELATIONSHIP WITH NUTRITIONAL-STATUS, International journal of clinical & laboratory research, 26(1), 1996, pp. 37-42
Authors:
BRANCHI A
ROVELLINI A
SOMMARIVA D
Citation: A. Branchi et al., DIFFERENTIAL-EFFECTS OF SIMVASTATIN AND BEZAFIBRATE ON APOLIPOPROTEIN-DEFINED HIGH-DENSITY-LIPOPROTEIN SUBFRACTIONS IN PATIENTS WITH HYPERCHOLESTEROLEMIA, Current therapeutic research, 57(1), 1996, pp. 26-32
Authors:
BRANCHI A
ROVELLINI A
FIORENZA AM
SOMMARIVA D
Citation: A. Branchi et al., EFFECTS OF BEZAFIBRATE AND OF 2 HMG-COA REDUCTASE INHIBITORS ON LIPOPROTEIN-(A) LEVEL IN HYPERCHOLESTEROLEMIC PATIENTS, International journal of clinical pharmacology and therapeutics, 33(6), 1995, pp. 345-350
Authors:
BRANCHI A
ROVELLINI A
SOMMARIVA D
Citation: A. Branchi et al., EFFECT OF BEZAFIBRATE ON HDL WITH APO A-I AND APO A-II AND ON HDL WITH APO A-I WITHOUT APO A-II IN HYPERLIPIDEMIC PATIENTS, International journal of clinical pharmacology research, 15(4), 1995, pp. 153-158
Authors:
BRANCHI A
ROVELLINI A
FIORENZA AM
TORRI A
PRANDI W
TOMELLA C
MOLGORA M
CARDENA A
VELATI C
ARCANGELI L
SOMMARIVA D
Citation: A. Branchi et al., ESTIMATION OF CARDIOVASCULAR RISK - TOTAL CHOLESTEROL VERSUS LIPOPROTEIN PROFILE, International journal of clinical & laboratory research, 24(2), 1994, pp. 106-112
Authors:
BRANCHI A
ROVELLINI A
SOMMARIVA D
BAGGIO E
GANDINI R
MARAFFI F
MONTALTO C
FASOLI A
Citation: A. Branchi et al., CIRCADIAN PLASMA-CONCENTRATION OF LIPOPROTEIN(A) AND DISTRIBUTION OF APOPROTEIN(A) IN HEALTHY-SUBJECTS, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 4(2), 1994, pp. 83-87
Authors:
BRANCHI A
ROVELLINI A
SOMMARIVA D
GUGLIANDOLO AG
FASOLI A
Citation: A. Branchi et al., EFFECT OF 3 FIBRATE DERIVATIVES AND OF 2 HMG-COA REDUCTASE INHIBITORSON PLASMA-FIBRINOGEN LEVEL IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, Thrombosis and haemostasis, 70(2), 1993, pp. 241-243
Risultati:
1-19
|